References
- Gandhi J, Chen A, Dagur G, et al. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol 2016;215:704–11
- Mac Bride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clin Proc 2010;85:87–94
- Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause 2013;20:888–902
- Gambacciani M, Levancini M, Cervigni M. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause. Climacteric 2015;18:757–63
- Gambacciani M, Levancini M, Russo E, Vacca L, Simoncini T, Cervigni M. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause. Climacteric 2018;21:148–52
- Gaspar A, Brandi H, Gomez V, Luque D. Efficacy of erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. Lasers Surg Med 2017;49:160–8
- Zerbinati N, Serati M, Origoni M, et al. Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment. Lasers Med Sci 2015;30:429–36
- Pitsouni E, Grigoriadis T, Zacharakis D, et al. CO2-laser therapy in women with severe symptoms of vaginal atrophy: a pilot histopathological study. Oral Abstract, presented at 9th EUGA Annual Congress. Eur J Obstet Gynecol Reprod Biol 2017;211:199–209. https://www.ejog.org/article/S0301-2115(17)30031-3/pdf
- Gaspar A, Maestri S, Silva J, et al. Intraurethral erbium:YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: a pilot study. Laser Surg Med 2018;50:802–7
- Lapii GA, Yakovleva AY, Neimark AI. Structural reorganization of the vaginal mucosa in stress urinary incontinence under conditions of Er:YAG laser treatment. Bull Exp Biol Med 2017;162:510–14